Adjunctive Withania Somnifera (Ashwagandha) for Persistent Symptoms in People With Schizophrenia

NCT03437668 · clinicaltrials.gov ↗

PHASE2,PHASE3

Phase

TERMINATED

Status

47

Enrollment

OTHER

Sponsor class

Stopped Unable to reach enrollment target due to COVID

Conditions

Schizophrenia

Interventions

DRUG: WSE
DRUG: Placebo Oral Tablet

Sponsor

Chengappa, K.N. Roy, MD

Collaborators

[object Object]
[object Object]